American Pharmacists Association applauds FTC action on PBMs' alleged inflation of insulin drug prices
Hogue, PharmD, FAPhA, FNAP, FFIP, executive vice president and CEO of APhA, commended the Federal Trade Commission's (FTC) action today against alleged practices by large vertically integrated pharmacy benefit managers (PBMs) "for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs,
The fall of 2023 was filled with frustration from customers across Kansas City forced to find new pharmacy options.
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
The leading brand in sex tech innovation, Satisfyer was established in 2016 when it set the tone with the launch of its ...
A pedestrian was injured Friday morning when a vehicle hit a CVS Pharmacy in Carolina Forest. Horry County Fire Rescue ...
Oak Street Health, a subsidiary of CVS, is paying $60 million to the federal government to resolve allegations that it ...
This week's dividend activity included increased payouts from Microsoft (NASDAQ:MSFT) and JPMorgan (NYSE:JPM) as well as ...
Newly updated covid vaccines that protect against the current variant are now available in Southwest Virginia at CVS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback